Cytoreductive Surgery and Heated Chemotherapy for Gastrointestinal Cancers
Recent advances in cancer treatments provide Johns Hopkins more effective treatment options for certain late stage cancers than ever before. A technique called cytoreductive (debulking) surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to be an effective treatment option for certain peritoneal surface malignancy cancers such as selected stage IV colon cancer and other gastrointestinal cancers including appendiceal cancers and pseudomyxoma peritonei. The peritoneal cavity is a space wrapped between two membranes layering the abdominal wall and organs around the abdomen.
The technique is a two-step process:
During the second phase of treatment a heated chemotherapy solution is circulated in the abdominal cavity to treat any cancer cells that may remain. The combination of heat and chemotherapy is believed to be more effective than standard chemotherapy treatment for certain patients because it can access and kill more cancer cells than can be found with the naked eye.
Johns Hopkins physicians will work with your doctors to determine if the heated chemotherapy wash may be an effective treatment for you.
Quality of Care
Recent studies have shown that cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy is beneficial for certain patients with late-stage gastrointestinal cancers such as colorectal cancers. The procedure can potentially extend their life and also improve quality of life for patients with late stage disease. Since the chemotherapy is delivered internally, some of the traditional side effects of oral or intravenous chemotherapy drugs are avoided.
A Johns Hopkins surgeon can determine if cytoreductive surgery and heated chemotherapy is the right treatment option for you or your patient. For a consultation, call: 410-933-1233.